Ready to buy? Check current prices on Amazon and compare deals before you decide.
Perimenopause is a time of significant hormonal shifts, and for many women, this can bring new or changing health considerations. The thyroid gland, a key player in metabolism and energy, is often a focus during this phase. Some women may explore natural options like ashwagandha (Withania somnifera) for support.
This article examines the current evidence regarding ashwagandha’s potential effects on thyroid function, particularly for women navigating perimenopause. We’ll look at what research suggests about its safety and efficacy, keeping in mind the importance of a balanced, evidence-based perspective.
Understanding Thyroid Function in Perimenopause
The thyroid gland produces hormones that regulate numerous bodily functions, including metabolism, energy levels, and body temperature. During perimenopause, fluctuations in estrogen and progesterone can sometimes influence thyroid hormone production and sensitivity, potentially leading to symptoms that overlap with both perimenopause and thyroid imbalances. These can include fatigue, weight changes, mood shifts, and changes in hair and skin.
Ashwagandha’s Traditional Use and Modern Interest
Ashwagandha is an herb with a long history of use in traditional Ayurvedic medicine. It is often categorized as an adaptogen, meaning it’s believed to help the body adapt to stress. This adaptogenic quality is one reason women in perimenopause might consider ashwagandha, as stress can impact overall well-being and hormonal balance. The plant’s roots are typically used in supplements.
What Does the Evidence Say About Ashwagandha and Thyroid Function?
While ashwagandha is a popular supplement, specific, high-quality studies directly investigating its effects on thyroid function in perimenopausal women are limited. Much of the interest in ashwagandha for thyroid support stems from its broader adaptogenic properties and some research on its impact on stress and general well-being. It is important to note that some literature discusses ashwagandha’s potential interplay with hormonal dynamics and gut microbiota in women with breast cancer, which hints at its systemic effects, but this is not directly related to perimenopausal thyroid support [1].
Safety Considerations for Ashwagandha and Thyroid Health
Safety is a paramount concern when considering any supplement, especially for women in perimenopause who may be experiencing hormonal shifts. While some studies have explored the efficacy and safety of ashwagandha in specific populations, such as pregnant women, these findings are not directly transferable to perimenopausal women or thyroid-specific outcomes [2].
It is crucial to be aware that there have been reports of adverse reactions. For instance, one publication documented a case of thyrotoxicosis, a condition characterized by excessive thyroid hormone, following the use of ashwagandha [3]. This suggests that ashwagandha may influence thyroid hormone levels and should be used with caution, particularly by individuals with pre-existing thyroid conditions or those taking thyroid medication.
The interaction of ashwagandha with the body’s hormonal systems is complex. While research is ongoing into its broader effects, such as its interplay with hormonal dynamics and gut microbiota, this research is not specific to perimenopausal thyroid health and does not provide direct evidence for its safety or efficacy in this context [1]. Women should always discuss any new supplements with their healthcare provider.
Ashwagandha vs. Other Herbs for Menopausal Symptoms
It’s helpful to distinguish ashwagandha from other herbal supplements that have been studied more directly for menopausal symptoms. For example, Shatavari (Asparagus racemosus) root extract has been the subject of randomized, double-blind, placebo-controlled studies specifically investigating its efficacy and safety for menopausal symptoms [4]. Shatavari has also been studied for its effects on sexual wellness in women [5]. These studies provide more direct evidence for specific perimenopausal concerns than currently exists for ashwagandha’s role in thyroid support during this phase.
References
- The interplay of Ashwagandha with hormonal dynamics and gut microbiota in women with breast cancer: a tri-axial perspective. Journal of natural medicines, 2026
- Efficacy and safety of Ashwagandha (Withania somnifera) root extract in pregnant women: a prospective, randomized, comparative, open-label, 12-week study. Frontiers in global women’s health, 2026
- [Thyrotoxicosis following the use of ashwagandha]. Nederlands tijdschrift voor geneeskunde, 2005
- Efficacy and safety of Shatavari root extract (Asparagus racemosus) for menopausal symptoms: a randomized, double-blind, three-arm, placebo-controlled study. Frontiers in reproductive health, 2025
- Effects of Shatavari (Asparagus racemosus) Root Extract on Sexual Wellness in Women: Findings from a Prospective, Randomized, Double-Blind, Three-Arm, Parallel-Group, Placebo-Controlled Study. International journal of women’s health, 2026
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
